Navigation Links
Orcrist Bio Inc. Files with European Competent Authority for a Phase I, Open-label, Single-ascending-dose, Safety Study of HYC750
Date:2/9/2009

eve a very strong clinical trial application has been submitted."

About Orcrist Bio Inc.

Orcrist Bio Inc. is a biotechnology company dedicated to developing and commercializing promising therapeutics for areas in which a clear market opportunity exists. ORC's lead program revolves around HYC750, a novel stem cell mobilizer compound that promotes the egress of stem cells and other blood cells from the bone marrow into the blood, from which they can be harvested and applied toward treating chemotherapy-related white blood cell depletion. Orcrist is actively looking to add to its pipeline exploring the innate properties of HYC750 and its effects on stem cells, as well as through in-licensing opportunities of other products with clear market potential. ORC is located in Calgary, Alberta. The company is financed by its founders and by private investors.

About Kinesis Pharma BV

Kinesis Pharma BV is an independent, privately owned company based in The Netherlands. Kinesis aims to facilitate a fast and high quality drug development process in close collaboration with the preclinical and clinical R&D departments of pharmaceutical and biotech companies through consultancy and contract research services. Currently, Kinesis employs about 55 people, many of them with extensive industrial and/or regulatory experience.

About InPEC BV

InPEC BV is a clinical CRO that focuses on the execution of Phase I and IIa clinical trials. Its professional and experienced team, and state of the art facilities, embedded within the care of a private hospital with an ICU unit on the same floor, guarantee maximum safety for the full range of clinical pharmacology studies. Electronic data processing procedures are in place to enable high-quality and efficient data processing on-site. InPEC's head office is located in the Netherlands. Clinical facilities are located in Malaga, Spain.


'/>"/>
SOURCE Orcrist Bio Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Tigris Pharmaceuticals Files IND Application for GGTI-2418
2. Panda Ethanols Hereford, Texas Subsidiary Files Voluntary Chapter 11
3. Stem Cell Innovations, Inc., Files New Patent Application
4. Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission
5. ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)
6. 3SBio Inc. Files for SFDA Approval of NuLeusin
7. 3SBio Inc. Files for SFDA Approval of High-dose (36,000 IU) EPIAO
8. Sangui BioTech International, Inc. Files Remaining Reports
9. VentriPoint Diagnostics Files Management Discussion and Analysis, Unaudited Financial Results for 2Q 2008
10. China-Biotics, Inc. Files Application for Nasdaq Listing
11. Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Affiliates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Madison, WI (PRWEB) April 17, 2015 ... provide sales and marketing support for the powerful ... at the Chemical Genomics Center at the Lankenau ... LCGC’s mission is to measurably improve successful ... to HTS, by offering rare, drug-like libraries available ...
(Date:4/16/2015)... CAMBRIDGE, Mass. (PRWEB) April 16, 2015 ... of smart data solutions driven by Semantic Web ... provider of specialist information and services for the ... today announced that its joint solution ‘Smart Data ... named a finalist for the 2015 Bio-IT ‘Best ...
(Date:4/16/2015)... Irvine, CA (PRWEB) April 16, 2015 ... in the Buzz of BIO Contest for ... Industry Organization (BIO), the 2015 BIO International Convention will ... in Philadelphia, Pennsylvania. During the Buzz of BIO contest, ... like to see present at the conference. The community ...
(Date:4/16/2015)... According to the 2014 Liberty Mutual ... was ranked first among the leading causes of ... pushing, pulling, holding, carrying, or throwing and cost ... Round Company takes statistics like this very seriously. ... develop and design equipment that prevents these injuries ...
Breaking Biology Technology:BellBrook Labs and Lankenau Institute Partner to Accelerate Drug Discovery using Orthogonal Pooled Screening 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 2Cambridge Semantics and Informa Named Bio-IT Award Finalist for Smart Data Lake Solution for Clinical Trial and Competitive Intelligence 3Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 2Proove Bisociences to Participate in the Buzz of BIO at the 2015 BIO International Convention 3The David Round Company Helps Companies Meet OSHA Standards by Combining Safety, Ergonomics, and Productivity 2
... 7 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX:,ARI), a ... of,antibody therapeutics, today announced that it will deliver ... for,two of its anti-cancer antibody drug candidates. ... Francisco on September 7-8,Arius will report recent results ...
... Announces ofatumumab Appeared More Effective Than rituximab ... ... Genmab A/S,(OMX: GEN) announced today that ofatumumab (HuMax-CD20(R)) appeared more,effective ... than rituximab in a pre-clinical study. The CD20,antibodies were incubated ...
... Feynman presented a talk entitled There,s Plenty of Room at ... reason why humans couldn,t manipulate atoms. However, if atomic ... positions remains. How do you know what you have ... of Science, IBM and Imago have taken a seminal step ...
Cached Biology Technology:Arius Features Preclinical Data on Antibody Candidates at Two Conferences 2Arius Features Preclinical Data on Antibody Candidates at Two Conferences 3Genmab Announces Encouraging Preclinical Data for ofatumumab 2IBM and Imago find a crucial difficulty in semiconductor device scaling 2
(Date:4/14/2015)... Conn. , April 14, 2015 NXT-ID, ... a biometric authentication company focused on the growing mobile ... been nominated for the 2015 New York Design Awards ... The Design100, New York City Design Awards are part ... based on over 2,500 ratings from the marketplace, industry ...
(Date:4/13/2015)... April 13, 2015  higi, a leading cloud-based consumer ... more fully engage with their communities around health and ... protected and secure API.  ... most accessible, affordable, and convenient vehicle to receive validated ... The API will allow higi,s trusted ...
(Date:4/9/2015)... SAN JOSE, Calif. , April 9, 2015 /PRNewswire/ ... of human interface solutions, announced today that it will ... 2015 on Thursday, April 23, 2015, after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2
... 2013 -- Resveratrol, a naturally occurring polyphenol compound produced ... found in red wine, has been touted as a ... This has been supported by some experimental studies, whereas ... using two multiple sclerosis (MS) models published in ...
... metabolic pathway for breaking down glucose that could lead to ... The new pathway is intended to replace the ... reactions that nearly all organisms use to convert sugars into ... the six carbon atoms found in glucose into two-carbon molecules ...
... a diverse team of University of Pittsburgh scientists to report ... that they had solved the mystery of a basic ... mechanism by which mitochondria tiny structures inside cells often ... and need to be eliminated, the Pitt team has opened ...
Cached Biology News:Resveratrol, found in red wine, worsens MS-like symptoms and neuropathology in mice 2Resveratrol, found in red wine, worsens MS-like symptoms and neuropathology in mice 3UCLA engineers develop new metabolic pathway to more efficiently convert sugars into biofuels 2When cells 'eat' their own power plants; Pitt scientists solve mystery of cellular process 2When cells 'eat' their own power plants; Pitt scientists solve mystery of cellular process 3
Mouse Endoglin/CD105 Fluorescein MAb (Clone 209701)...
... is an inhibitor of ... concentration of inhibitor required ... must be determined empirically ... micromolar inhibitor is sufficient ...
...
SNARE associated protein snapin, clone MGC:2717...
Biology Products: